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Enzyme replacement
Mutation of transglutaminase 1 (TG1), which is critical in the 
formation of the cornified envelope that functions as a barrier to 
transepidermal water loss and infection, results in the severe and 
ultrarare genetic disorder TG1-deficient autosomal congenital 
ichthyosis (ARCI). Unfortunately, no suitable therapy that targets 
the underlying molecular basis is available, and current therapy 
regimes are insufficient and directed at symptom improvement. 
To explore a possible new topical therapy for this burdensome 
disease, Aufenvenne and colleagues developed sterically stabi-
lized liposomes that encapsulate recombinant human TG1 and 
contain a highly cationic, uptake-mediating lipopeptide incor-
porated into the liposomal surface. These liposomes were read-
ily internalized and restored TG1 function in cells. In a mouse 
model of ARCI, treatment with these liposomes resulted in 
remarkable improvement in the ichthyosis phenotype, including 
restoration of TG1 activity. Following this enzyme-replacement 
therapy, these mice exhibited reconstituted epidermal integ-
rity and restored epidermal barrier function, supporting further 
investigation of this strategy for treatment of ARCI. (Am J Hum 
Genet 93:620–30, 2013) Selected by J. Uitto
Bacteria are such a pain
Staphylococcus aureus is an important cause of surgical and 
wound infections, which lead to painful abscesses, cellulitis, and 
necrotizing fasciitis. Bacterial infection causes inflammation via 
recruitment of immune cells, which secrete cytokines, growth fac-
tors, and other mediators that are thought to trigger inflammatory 
pain during infection. Chiu and colleagues recently investigated 
the mechanisms of pain generation during S. aureus infection 
and demonstrated that bacteria actually directly activate nocicep-
tors and contribute to hyperalgesia in vivo. N-formylated peptides 
and α-hemolysin, a pore-forming toxin, induced direct neuronal 
responses. Surprisingly, suspect immune activation pathways were 
unnecessary for hyperalgesia during acute infection, although evi-
dence suggests that these immune players contribute at later stages 
of infection. Furthermore, upon infection, nociceptors released 
neuropeptides that appeared to modulate the innate immune 
response directly. Together these results indicate a direct pathogen-
mediated activation of nociceptors, leading to downregulation of 
the local inflammatory response during acute infection of S. aure-
us. (Nature 501:52–7, 2013) Selected by R. Gallo
In the cards
Deep dermatophytosis is a rare, invasive, and potentially life-
threatening fungal infection that appears to be inherited as an 
autosomal recessive trait. Deficiency in caspase recruitment 
domain–containing protein 9 (CARD9) has been reported pre-
viously in association with other fungal-infection disorders, 
although deep dermatophytosis has not been associated with any 
of these disorders. Lanternier and colleagues, using a candidate-
gene approach to probe the underlying genetic cause of deep 
dermatophytosis in 17 patients from eight unrelated kindreds, 
identified autosomal recessive CARD9 deficiency as a potential 
genetic cause of deep dermatophytosis because all patients with 
idiopathic disease carried biallelic, rare, deleterious mutations in 
CARD9. In this study, two new CARD9 mutations—one missense 
(R101C) and one nonsense (Q289X)—were identified. These 
results add to the numbers of life-threatening infectious diseases 
that are associated with single-gene inherited errors of immunity. 
(N Engl J Med 369:1704–14, 2013) Selected by K. Reddy
Searching for clues
The molecular basis of Cole disease, a rare autosomal domi-
nant disorder characterized by congenital or early-onset punc-
tate keratoderma and hypopigmented macules on the arms and 
legs, has remained elusive since its description in 1976. Studies 
of candidate genes associated with overlapping phenotypes, 
such as epidermolysis bullosa simplex with mottled pigmenta-
tion and Naegeli syndrome, failed to identify the underlying 
affected genes. Eytan and colleagues employed a genome-wide 
approach to examine three families affected by this disorder. 
These studies identified ENPP1, the gene encoding the cell sur-
face protein ectonucleotide pyrophosphatase/phosphodiesterase 
1, as the only gene to harbor three distinct mutations in these 
families. Three cysteine mutations, which were predicted to be 
involved in intermolecular disulfide bonds, were clustered in the 
somatomedin-B-like 2 domain, which has been implicated in 
insulin signaling. Taken together, these findings implicate ENPP1 
in the regulation of epidermal differentiation and pigmentation. 
(Am J Hum Genet 93:752–7, 2013) Selected by B.A. Gilchrest
Illuminating tumor margins
The availability of tumor diagnosis and imaging during surgery 
is important because this information allows complete removal 
of tumor cells without sacrificing healthy tissue. Such a tissue-
conserving surgery strategy—e.g., Mohs micrographic surgery 
(MMS)—currently relies on the time-consuming and costly 
methods of histopathology, which render an inherently subjec-
tive diagnosis. Previously, quantitative diagnosis based on spec-
tral information of tissues was reported for various cancer types. 
In a recent paper, Kong and colleagues described an integrated 
optical technique involving this spectral information for intraop-
erative diagnosis of basal cell carcinoma. This approach, which 
is based on tissue autofluorescence imaging and Raman scatter-
ing, measures molecular differences between tumor cells and 
healthy tissue to provide an objective diagnosis of tumors quickly 
and without tissue sectioning or staining. This method enabled 
objective diagnosis of basal cell carcinoma in skin tissue samples 
excised during MMS and in unsectioned tissue layers, confirming 
the potential of this technique to spare healthy tissue yet ensure 
removal of all tumor cells during surgery. (Proc Natl Acad Sci USA 
110:15189–94, 2013) Selected by B.A. GilchrestJournal of Investigative Dermatology (2014) 134, 301. doi:10.1038/jid.2013.520
